← All organizations
Topokine Therapeutics

Topokine Therapeutics

For profit

Also known as: Topokine Therapeutics, Inc.

Highest phase reached

Phase 3

First clinical trial

Nov 1, 2012

Last known activity

Jan 1, 2016

Acquired by Allergan PLC (2015)AbbVie on Apr 22, 2016

Timeline

2010s

  1. Jan 1, 2010

    Topokine Therapeutics— Founded

  2. Apr 22, 2016

    Allergan PLC (2015)— Acquired By

  3. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (2 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

Details

Founded
Boston, MA, US Jan 1, 2010
Last known activity
Jan 1, 2016